Envisia Therapeutics Inc. — Form D
Envisia Therapeutics Inc. of Morrisville, NC, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-22. The offering totals $69.4M, of which $15.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2013-11-22
- Form: D
- Accession: 0001591924-13-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $69.4M
- Amount sold: $15.2M
- Remaining: $54.2M
- Investors: 12
- Date of first sale: 2013-11-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-206825
Issuer
- Name: Envisia Therapeutics Inc.
- CIK: 0001591924
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 419 Davis Dr. Suite 100, Morrisville, NC, 27560
- Phone: 919-973-1440
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Stephen Bloch | Director | Parsippany, NJ |
| Neal Fowler | Director | DURHAM, NC |
| Ed Mathers | Director | TIMONIUM, MD |
| Seth Rudnick | Director | DURHAM, NC |
| Tim Albury | Executive Officer | MORRISVILLE, NC |
| Neal Fowler | Executive Officer | DURHAM, NC |
| Shawn Glidden | Executive Officer | MORRISVILLE, NC |
More